Ligufalimab (AK 117) is a humanized IgG4 monoclonal antibody targeting CD47. This antibody is engineered to avoid the induction of red blood cell (RBC) hemaglutination, while effectively promoting phagocytosis. Ligufalimab has demonstrated significant anti-tumor activity in various models, making it a valuable tool for research in cancer immunotherapy.
Ligufalimab (AK 117) is a humanized IgG4 monoclonal antibody targeting CD47. This antibody is engineered to avoid the induction of red blood cell (RBC) hemaglutination, while effectively promoting phagocytosis. Ligufalimab has demonstrated significant anti-tumor activity in various models, making it a valuable tool for research in cancer immunotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
